Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Numinus Wellness Focused on Boosting Profitability and Expanding Community Support (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Dr Reddys Laboratories ADR repsg 1 Ord Shs RDY

Healthcare
Dr. Reddy’s Laboratories Limited is an India-based global pharmaceutical company. The Company offers a portfolio of products and services, including active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC). Its major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. The... see more

Recent & Breaking News (NYSE:RDY)

22 Stocks Moving In Friday's Pre-Market Session

Benzinga.com  August 11, 2017

Dr. Reddy’s and CHD Bioscience Announce Global License and Commercialization Agreement for Phase III Clinical Trial Candidate for Mitigation of Surgical Site Infections

Business Wire July 27, 2017

Dr. Reddy’s Q1 FY18 Financial Results

Business Wire July 27, 2017

Investor Network: Dr. Reddy's Laboratories Ltd. to Host Earnings Call

Accesswire July 27, 2017

Dr. Reddy's to Release Q1 FY18 Results on July 27, 2017

Business Wire July 14, 2017

Dr. Reddy's Laboratories Announces the Launch of Bivalirudin for Injection in the U.S. Market

Business Wire June 6, 2017

Dr. Reddy's Laboratories Limited to Present at the Jefferies 2017 Global Healthcare Conference

Business Wire June 5, 2017

25 Stocks Moving In Wednesday's Pre-Market Session

Benzinga.com  May 24, 2017

Elite Pharmaceuticals Acquires Trimipramine ANDA

GlobeNewswire May 22, 2017

Dr. Reddy's Laboratories Announces USFDA Approval for the Launch of Doxorubicin Hydrochloride Liposome Injection in the U.S. Market

Business Wire May 17, 2017

Dr. Reddy’s Q4 and FY17 Financial Results

Business Wire May 12, 2017

Agios and Aurigene Enter into Exclusive License Agreement for Novel Small Molecules for Cancer Metabolism Target

GlobeNewswire April 27, 2017

Dr. Reddy's Laboratories Announces the Launch of Ezetimibe and Simvastatin Tablets in the U.S. Market

Business Wire April 27, 2017

Dr. Reddy's Laboratories Announces the Launch of Progesterone Capsules in the U.S. Market

Business Wire April 21, 2017

Dr. Reddy’s and Integra LifeSciences Enter into an Agreement to Market and Distribute DuraGen Plus® and Suturable DuraGen® Dural Regeneration in India

Business Wire March 27, 2017

CytoSorbents Announces CytoSorb® Partnership with Dr. Reddy's Laboratories

PR Newswire March 16, 2017

Dr. Reddy's Expands Commercial Operations in Europe

PR Newswire Europe Non Regulatory February 8, 2017

Dr. Reddy’s Q3 and 9M FY17 Financial Results

Business Wire February 4, 2017

Lifshitz & Miller LLP Announces Investigation of Dr. Reddy's Laboratories Limited, Exterran Corporation, Gigamon Inc., KemPharm, Inc., Navient Corporation, NCI, Inc., Opus Bank, PixarBio Corporation and Yahoo! Inc.

PR Newswire February 3, 2017

Johnson & Weaver, LLP Announces Investigations of Pearson plc., BT Group plc, Dr. Reddy's Laboratories Ltd. and OneMain Holdings, Inc.

PR Newswire January 25, 2017